Histopathologic Approaches to Detect Changes Indicative of Immunotoxicity

Toxicologic Pathology

Volumn 28, Issue 3, 2000, Pages 454-466

  Kuper, C Frieke ^a   Harleman, Johannes H ^b   Richter Reichelm, Hans B ^c   Vos, Joseph G ^d  

^a TNO   (Netherlands)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Federal Institute for Health Protection of Consumers and Veterinary Medicine   (Germany)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

immunomodulation; immunosuppression; lymph node; Lymphoid organs; morphology; mucosa associated lymphoid tissue (MALT); spleen; thymus

Indexed keywords

ANIMAL TISSUE; CELL STRUCTURE; HISTOPATHOLOGY; IMMUNOMODULATION; IMMUNOTOXICITY; LYMPH NODE; LYMPHOID ORGAN; LYMPHOID TISSUE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN; THYMUS;

ANIMALS; FEMALE; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTOXINS; LYMPHOID TISSUE; MALE; RATS;

ANIMALIA; RODENTIA;

EID: 0034130174     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262330002800317     Document Type: Article

References (44)

1. Arts Jhe, Kuper CF, Spoor SM, Bloksma N. (1998). Airway morphology and function of rats following dermal sensitization and respiratory challenge with low molecular weight chemicals. Toxicol Appl Pharmacol 152: 66-76.
2. Bos J (ed) (1990). The Skin Immune System. CRC Press, Boca Raton, Florida.
3. Brown AR (1992). Immunological functions of splenic B-lymphocytes. Crit Rev Immunol 11: 395-417.
4. Bruder MC, Spanhaak S., Bruijntjes JP, Michielsen Cppc, Vos JG, Kuper CF (1999). Intestinal T-lymphocytes of different rat strains in immunotoxicity. Toxicol Pathol 27: 171-179.
5. Bruijntjes JP, Kuper CF, Robinson JE, Schuurman HJ (1993). Epithelium-free area in the thymic cortex of rats. Dev Immunol 3: 113-122.
6. Dean JH (1997). Issues with introducing new immunotoxicology methods into the safety assessment of pharmaceuticals. Toxicology 119: 95-101.
7. De Bakker JM, Kammueler ME, Muller Esm, Lam AW, Seinen W., Bloksma N. (1990). Kinetics and morphology of chemically-induced popliteal lymph node reactions in comparison with antigen-, mitogen-, and graft versus host reaction induced responses. Virchows Archiv B 58: 279-287.
8. De Boer NK, Kroese Fgm, Sharp JG, Perry GA (1992). Immunohistological characterization of proximal clonic lymphoid tissue in the rat. Anat Rec 233: 569-576.
9. De Waal EJ, Schuurman HJ, Van Loveren H., Vos JG (1997). Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, bis(tri-n-butyltin)oxide and cyclosporine on thymus histophysiology. CRC Cric Rev Toxicol 27: 381-430.
10. Gopinath C. (1996). Pathology of toxic effects on the immune system. Inflamm Res 45(suppl 2): S74-S78.
11. Greaves P. (1990). Haemopoietic and lymphatic systems. In: Histopathology of Preclinical Toxicity Studies Elsevier, Amsterdam, pp 77-115.
12. Greenstein BD, Fitzpatrick Fta, Kendall MD, Wheeler MJ (1987). Regeneration of the thymus in old male rats treated with a stable analogue of LHRH. J Endocrinol 112: 345-350.
13. Hastings KL, Chang-Ho A., Alam SN, Aszalos A., Young SC, Jessop JJ, Weaver JL (1997). Points to consider for assessment of the immunotoxic potential of investigational new drugs: FDA perspective. Drug Inf J 31: 1357-1362.
14. Hinton DM (1995). Immunotoxicity testing applied to direct food and colour additives: US FDA “Redbook II” guidelines. Hum Exp Toxicol 14: 143-145.
15. Houben GF, Penninks AH, Seinen W., Vos JG, Van Loveren H (1993). Immunotoxic effects of the color additive caramel color. III: Immune function studies in rats. Fundam Appl Toxicol 20: 30-37.
16. International Collaborative Immunotoxicity Study (ICICIS) Group Investigators (1998). Report of validation study of assessment of direct immunotoxicity in the rat. Toxicology 125: 183-210.
17. International Programme for Chemical Safety (IPCS) (1996). Principles and Methods for Assessing Direct Immunotoxicity Associated with Chemical Exposure. International Programme for Chemical Safety, Environmental Health Criteria Document No 160, World Health Organization, Geneva.
18. Jones JC, Ward JM, Mohr U, Hunt RD (eds) (1990). Hemopoietic System. Springer-Verlag, Berlin.
19. Kanamori Y., Ishimaru K., Nanno M., Maki K., Ikuta K., Nariuchi H., Ishikawa H. (1996). Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit +IL-JR+Thy1+ lympho-hemopoietic progenitors develop. J Exp Med 184: 1449-1459.
20. Koeter Hbwm (1995). International harmonisation of immunotoxicity testing. Hum Exp Toxicol 14: 151-154.
21. Kuper CF, Beems RB, Bruijntjes JP, Schuurman HJ, Vos JG (1992). Normal development, growth and aging of the thymus. In: Pathobiology of the Aging Rat, Vol 1, Mohr U, Dungworth DL, Capen CC (eds). ILSI Press, Washington, D.C., pp 25-49.
22. Kuper CF, Koornstra PJ, Hameleers Dmh, Biewenga J., Spit BJ, Duijvestijn AM, Van Breda Vriesman Pjc, Sminia T. (1992). The role of naspharyngeal lymphoid tissue. Immunol Today 13: 219-224.
23. Kuper CF, Schuurman HJ, Vos JG (1995). Pathology in immunotoxicology. In: Methods in Immunotoxicology, Vol 1, Burleson GR, Dean JH, Munson AE (eds). Wiley-Liss, New York, pp 397-436.
24. Ladicz GS, Smith C., Heaps K., Ellioo GS, Slone TW, Loveless SE (1995). Possible incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats on standard toxicology study. Toxicology 96: 225-238.
25. Luster MI, Munson AE, Thomas PT, Holsapple MP, Fenters JD, White KL, Lauer LD, Germolec DR, Rosenthal GJ, Dean JH (1988). Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam Appl Toxicol 10: 2-19.
26. Luster MI, Portier C., Pait DG, Rosenthal GJ, Germolec DR, Corsini E., Blaylock BL, Pollock P., Kouchi Y., Craig W., White KL, Munson AE, Comment CE (1993). Risk assessment in immunotoxicology. II. Relationship between immune and host resistance tests. Fundam Appl Toxicol 21: 71-82.
27. Mackall CL, Punt JA, Morgan P., Farr AG, Gress RE (1998). Thymic function in young/old chimeras: Substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. Eur J Immunol 28: 1886-1893.
28. Majoor GD, Wodzig WH, Vriesman Pjcvb (1991). Cyclosporininduced autoimmunity. In: Thymus Update: Thymus in Immunotoxicology, Kendall MD, Ritter MA (eds). Harwood Academic, London, pp 179-200.
29. Michielsen Cppc, Bloksma N., Ultee A., Van Mil F., Vos JG (1997). Hexachlorobenzene-induced immunomodulation and skin and lung lesions: A comparison between Brown Norway, Lewis, and Wistar rats. Toxicol Appl Pharmacol 144: 12-26.
30. Organisation for Economic Cooperation and Development (1996). Report of the OECD Immunology Work Group Meeting, Research Triangle Park, NC, 11-12 December. Organisation for Economic Co-operation and Development, Paris.
31. Richter-Reichhelm HB, Dasenbrock CA, Descotes G., Emmendörfer AC, Ernst HU, Harleman JH, Hildebrand B., Küttler K., Rühl-Fehlert CI, Schilling K., Schulte AE, Vohr HW (1995). Validation of a modified 28-day rat study to evidence effects of test compounds on the immune system. Regul Toxicol Pharmacol 22: 54-56.
32. Rose NR, Caturegli PP (1997). Environmental and drug-induced autoimmune diseases of humans. In: Comprehensive Toxicology, Vol 5, Lawrence DA (ed). Pergamon, Oxford, United Kingdom, pp 381-391.
33. Sainte-Marie G., Bélisle C., Peng FS (1990). In: Reaction Patterns of the Lymph Node. Part I. Cell Types and Functions, Grundmann E, Vollmer E (eds). Springer-Verlag, Berlin, pp 33-63.
34. Schuurman HJ, Krajnc-Franken Mam, Kuper CF, Van Loveren H, Vos JG (1991). Immune system. In: Handbook of Toxicologic Pathology, Haschek WM, Rousseaux CG (eds). Academic Press, San Diego, California, pp 421-487.
35. Van Ewijk W (1991). T-cell differentiation is influenced by thymic micro-environments. Annu Rev Immunol 9: 591-615.
36. Van Loveren H, Vos JG (1989). Immunotoxicological considerations: A practical approach to immunotoxicity testing in the rat. In: Advances in Applied Toxicology, Dayan AD, Paine AJ (eds). Taylor and Francis, London, pp 143-165.
37. Van Loveren H., Vos JG, De Waal EJ (1996). Testing immunotoxicity of chemicals as a guide for testing approaches for pharmaceuticals. Drug Inf J 30: 275-279.
38. Vos JG (1980). Immunotoxicity assessment: Screening and function studies. Arch Toxicol Suppl 4: 95-108.
39. Vos JG (1986). Immunotoxicity of hexachlorobenzene. In: Hexachlorobenzene, Morris CR, Cabral JRP (eds). International Agency for Research on Cancer, Lyon, France, pp 347-356.
40. Vos JG, Dormans Jama, Kraal G., Krajnc EI, Krajnc-Franken Mam, Van Loveren H. (1990). Immunotoxicity of hexachlorobenzene is thymus-dependent. Toxicologist 10: 221.
41. Vos JG, Krajnc EI (1983). Immunotoxicity of pesticides. In: Developments in the Science and Practice of Toxicology, Hayes AW, Schnell RC, Miya TS (eds). Elsevier, Amsterdam, pp 229-240.
42. Vos JG, Kuper CF, Schuurman HJ (1997). Lymphoid tissue architecture and pathological influences of toxicants. In: Toxicology of the Immune System, Comprehensive Toxicology, Vol 5, Lawrence DA (ed). Elsevier, Oxford, United Kingdom, pp 113-129.
43. Weiss L., Geduldig U. (1991). Barrier cells: Stromal regulation of hematopoiesis and blood cell release in normal and stressed murine bone marrow. Blood 78: 975-990.
44. Williams N. (1998). T cells on the mucosal frontline. Science 280: 198-200.